https://blogs.mercola.com:443/sites/vitalvotes/archive/2021/04/21/vaccine-patent-gives-us-government-_1820_leverage_1920_-over-manufacturers.aspxThe U.S. government is using the leverage of public funding to finance and boost supplies of both Moderna&rsquo;s and Pfizer&rsquo;s COVID-19 vaccines, according to Financial Times. The National Institutes of Health holds patents that allow the agencyenCommunityServer 2008.5 SP1 (Debug Build: 31106.3070)https://blogs.mercola.com:443/sites/vitalvotes/archive/2021/04/21/vaccine-patent-gives-us-government-_1820_leverage_1920_-over-manufacturers.aspx?ShowAllComments=True#10779004/22/2021 1:19:26 AM24451277-a5aa-4add-96dc-64081bfd86fa:1077900Almond<p>Qui bono? &nbsp;(Who benefits?)</p> https://blogs.mercola.com:443/sites/vitalvotes/archive/2021/04/21/vaccine-patent-gives-us-government-_1820_leverage_1920_-over-manufacturers.aspx?ShowAllComments=True#10778234/21/2021 12:13:13 PM24451277-a5aa-4add-96dc-64081bfd86fa:1077823swdhj1<p>I don&#39;t get the point of this article. &nbsp;The federal government already filly funded the development and fast tracking of the vaccines using taxpayer dollars (in the amount of &gt;3000 Solyndras), plus the federal government is purchasing the vaccines, again, using taxpayer dollars. &nbsp;The royalties would just be a tiny kickback percentage of the total tax dollars spent.</p>